BetterLife Pharma (BETRF) Current Taxes (2021 - 2025)

BetterLife Pharma has reported Current Taxes for 5 years, with the latest figure at -$10.1 million in Q1 2025.

• On a quarterly basis, Current Taxes rose 6.93% year-over-year to -$10.1 million in Q1 2025; TTM through Jan 2025 was -$10.1 million, a 6.93% increase from a year earlier, with the FY2025 full-year figure at -$10.4 million, up 4.27% from the prior year.
• Current Taxes was -$10.1 million for Q1 2025 at BetterLife Pharma, down from $523407.0 in the prior quarter.
• The five-year high for Current Taxes was $850869.8 in Q2 2024, with the low at -$10.9 million in Q1 2024.
• Average Current Taxes over 5 years is -$1.8 million, with a median of $157346.3 recorded in 2023.
• The largest YoY upside for Current Taxes was 178.0% in 2024 against a maximum downside of 70951.9% in 2024.
• Over 5 years, Current Taxes stood at $397148.8 in 2021, then sank by 68.17% to $126417.8 in 2022, then soared by 48.93% to $188274.8 in 2023, then surged by 178.0% to $523407.0 in 2024, then tumbled by 2033.5% to -$10.1 million in 2025.
• The last three Current Taxes figures came in at -$10.1 million (Q1 2025), $523407.0 (Q4 2024), and $499690.4 (Q3 2024), per Business Quant data.